Medicines Australia says it has been and is still advocating against secrecy provisions

“We have been advocating that NDAs [non-disclosure agreements] are not required for Implementation Group discussions and that there needs to be broad consultation and co-design of responses to the recommendations. Medicines Australia, just like consumer groups and the clinicians, will need to consult with everyone we represent," said chief executive Liz de Somer. …